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Genetic testing and research have increased the de-
mand for high-quality DNA that has traditionally been
obtained by venipuncture. However, venous blood
collection may prove difficult in special populations
and when large-scale specimen collection or ex-
change is prerequisite for international collaborative
investigations. Guthrie/FTA card–based blood spots,
buccal scrapes, and finger nail clippings are DNA-
containing specimens that are uniquely accessible
and thus attractive as alternative tissue sources (ATS).
The literature details a variety of protocols for extrac-
tion of nucleic acids from a singular ATS type, but
their utility has not been systematically analyzed in
comparison with conventional sources such as ve-
nous blood. Additionally, the efficacy of each protocol
is often equated with the overall nucleic acid yield but
not with the analytical performance of the DNA dur-
ing mutation detection. Together with a critical in-
depth literature review of published extraction meth-
ods, we developed and evaluated an all-inclusive
approach for serial, systematic, and direct compari-
son of DNA utility from multiple biological samples.
Our results point to the often underappreciated value
of these alternative tissue sources and highlight ways
to maximize the ATS-derived DNA for optimal quan-
tity, quality, and utility as a function of extraction
method. Our comparative analysis clarifies the value
of ATS in genomic analysis projects for population-
based screening, diagnostics, molecular autopsy,
medico-legal investigations, or multi-organ surveys ofsuspected mosaicisms. (J Mol Diagn 2012, 14:451–457;
http://dx.doi.org/10.1016/j.jmoldx.2012.04.005)
The demand for genetic diagnosis is rising steeply, in-
cluding pre-emptive screening,1 diagnostics,2,3 adverse
reaction risk assessment,4 familial and population ge-
netic profiling,5 and molecular autopsy.6,7 This dramati-
cally increases the need for optimal collection and pro-
cessing so that samples are amenable to a wide range of
research and diagnostic applications and often to the
establishment of a renewable tissue source such as per-
petual cell lines.8 Blood and organ-derived specimens
possess many of these attributes; however, their procure-
ment often encounters logistical and ethical obstacles.
DNA-containing specimens, such as saliva, buccal spec-
imens, nail clippings, and blood spots, are alternative
tissue sources (ATS) that offer cost-effective, practical,
and non- or minimally invasive options that are appealing
to medical professionals and candidate research partic-
ipants. They are easy to collect, store, and ship, which is
especially important in large-scale national and interna-
tional familial or population screening programs and in
molecular autopsy.9–11
There are numerous published reports on processing
individual alternative samples using resulting DNA quan-
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optimal methodology or sample utility. Unfortunately, this
extensive technical knowledge base is inconsistent lack-
ing rationale for the chosen processing steps and rigor-
ous, systematic, comparative data on multiple ATS ver-
sus conventional blood samples with regard to their
performance in downstream applications. This has ham-
pered broader acceptance of alternative specimens as
valuable research and diagnostic material.
The objectives of this study were to analyze the com-
mon processing steps and develop an informed extrac-
tion approach for the most commonly and easily available
alternative samples such as blood spots, buccal
scrapes, and nail clippings, and to perform parallel com-
parison of ATS versus conventional samples with regard
to DNA quality, quantity, and genomic diagnostic ability.
We have placed the results of this analysis in both a
scientific and educational context that can be readily
used by all personnel involved in translational genomic
research and diagnostics.
Materials and Methods
Sample Collection
Volunteers self-collected the following alternative speci-
mens: i) blood spots on Guthrie or FTA cards (VWR,
Radnor, PA); ii) buccal scrapes on Guthrie or FTA cards;
iii) saliva into the commercial self-contained sponge re-
ceptacle (Oragene; DNA Genotek, Kanata, ON, Canada)
according to the manufacturer’s protocol; and iv) finger-
nail trimmings into a sterile 1.5-mL microcentrifuge tube.
Venous blood and cell line–derived DNA originated
from our institutional review board–approved and previ-
ously published Ion Channel in Epilepsy Project at Baylor
College of Medicine.5 Formalin-fixed, paraffin-embedded
(FFPE) sections were obtained from the Baylor College of
Medicine Sudden Unexpected Death in Epilepsy (SUDEP)
Bio-Repository. All but FFPE samples were compared from
the same individual to eliminate variation due to interin-
dividual differences.
Blood Spot on Guthrie/FTA Card
The ring finger on the nondominant hand was washed
and sterilized in alcohol. Sterile lancets were used to
puncture the dermis of the finger pad, and about 40 L of
blood was dropped into each of the five circles on the
card. The samples were then covered and allowed to dry
at room temperature. Cards were coded, de-identified,
and stored at room temperature until further use. The
blood spots were evaluated at three time points: fresh, ie,
as soon as the blood applied to the card was dry; 1 week,
following collection and storage; and aged, 3 or more
months after collection.
Buccal Scrape on Guthrie/FTA Card
Volunteers were asked not to eat or drink for 30 min-
utes before sample collection. The mouth was rinsed
twice with bottled water, and a sterile speculum was usedto scrape the inside of the cheek. Collected cells were
smeared onto the circle on the Guthrie card. Four addi-
tional samples were collected using a fresh speculum
each time and moving to a new location within the cheek.
Because of the irregular edges and translucent nature of
the dried buccal scrape, an outline of the sample on the
card was drawn using a graphite pencil. Samples were
then covered and allowed to dry at room temperature.
Cards were coded, de-identified, and stored at room
temperature until use.
Salivary Samples
Samples were collected and processed according to
the manufacturer’s instructions (DNA Genotek). Briefly,
volunteers were asked to not eat or drink for 30 minutes
before sample collection, rinse their mouth twice with
bottled water, and then spit into the tube up to the line
indicated on the container. Each subject collected about
3 to 4 mL of saliva, closed the tube, and then mixed the
sample thoroughly with the premeasured stabilizing so-
lution by inverting the tube several times. The sample was
stored at room temperature and processed within 7 days.
DNA was extracted as per the manufacturer’s instruc-
tions, using nuclease inactivation, particle precipitation,
and salt/alcohol precipitation.
Fingernail Trimmings as a Keratinized
Tissue–Derived DNA Source
In our experience in the Baylor SUDEP Tissue Donation
Program (STOP), many hair samples are received without
the follicle, and their integrity is often further compro-
mised due to prior chemical processing with hair prod-
ucts. This often leads to no detectable DNA or a speci-
men too inferior for serious consideration for systematic
sampling, analysis, and use in medical diagnostics. We
found fingernails to be a more reliable source of DNA
from a keratinized tissue. Volunteers with at least 1 week
of fingernail growth were asked to thoroughly wash their
hands with soap and warm water before sample collec-
tion and then allow their hands to air dry. Ten fingernails
from both hands were then self-collected with ethanol-
sterilized conventional metal nail clippers onto a clean
sheet of A5 paper. Whole nail trimmings were transferred
into the de-identified prelabeled microcentrifuge tube.
Fingernails were stored in the tube at room temperature
until use.
Formalin-Fixed Paraffin-Embedded Cortical Brain
Samples
Retrospective molecular autopsy of SUDEP individuals
often relies on the analysis of processed brain slices.
DNA from individual 15 m thick formalin-fixed, paraffin-
embedded de-identified brain cortical sections was ex-
tracted using several different protocols (n  4 sections
each).12–14 The QIAamp DNA Mini Kit (Qiagen, Valencia,
CA) with a xylene deparaffinization step was selected
because of the relative ease of use, consistent DNA yield,
and reproducible DNA quality.
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Venous blood samples were donated by healthy vol-
unteers.5 Briefly, informed consent was obtained, and
three vials of 8 mL of blood were drawn from each indi-
vidual. Two vials of each sample were used for immediate
extraction of genomic DNA using the Gentra Puregene
Blood Kit (Qiagen). DNA was stored in de-identified bar-
coded tubes at 80°C. One vial of blood from each
sample was sent to the Coriell Cell Repositories for gen-
eration of apublicly accessible cell-line archive (ccr.coriell.
org, last accessed April 28, 2012) (see below).
Cell Lines
A significant fraction of idiopathic epilepsy patients will
unfortunately die of SUDEP, and the archived cell lines
may be the only source of DNA in these individuals. We
therefore assessed the cell line–derived DNA in parallel
to the other tissue types. Purified DNA from the subject’s
cell line was obtained from the NINDS Human Genetics
DNA and Cell Line Repository.
DNA Extraction
Rehydration/Wash Step
To compare the effect of rehydration/wash solution, we
compared the detergent-containing solutions Tris-SDS
[0.1% SDS; 100 mmol/L Tris-HCl (pH 8.0)] and FTA Pu-
rification Reagent (Sigma-Aldrich, St. Louis, MO) to the
classic DNA rehydration solution Tris-EDTA (TE) [10
mmol/L Tris; 1 mmol/L EDTA (pH 8.0)], as washing agent.
Briefly, wash solution was added to the sample followed
by 10 minutes of shaking on a rotator at room tempera-
ture before being removed by pipette. Six replicates for
each wash for each ATS were performed.
Comparison of Two Different Washing Protocols
(Detergent Wash versus TE Wash Alone)
For both the FTA wash and Tris-SDS wash, three
500-L washes with the detergent-containing solution
were performed. This was followed by two 500-L TE
washes to remove detergent. For the TE-alone wash,
three 500-l washes were performed. After the final
wash, the sample was moved to the extraction step.
Extraction Step
We performed a comparison of extraction methods to
determine whether proteolytic digestion of the sample is
affected by temperature, time, and extraction buffer. En-
zymatic digestion of samples was performed using a
constant concentration of 25 L (25 mg/mL) Proteinase K
(ProK) (Roche, Basel, Switzerland) per 1 mL of buffer with
a total extraction volume of 250 L per sample. We tested
the effects of the extraction buffers sodium-Tris-EDTA
(STE) [10 mmol/L Tris; 1 mmol/L EDTA; 100 mmol/L NaCl
(pH 8.0)]; Phosphate Buffered Saline (PBS) [1.5 mmol/L
KH2PO4; 3 mmol/L Na2HPO4-7H2O; 155 mmol/L NaCl
(pH 7.2)]; or TE [10 mmol/L Tris; 1 mmol/L EDTA (pH 8.0)]on DNA yield using a water bath set to 37°C or 56°C.
Proteinase K was heat inactivated by 15-minute incuba-
tion at 94°C in a heat block after extraction. Five repli-
cates for each extraction buffer for each tissue were
performed at both temperatures.
Purification Step
We used the QIAamp Mini Spin Kit (Qiagen) to assess
the impact of purification on the quantity, quality, and
utility of the ATS DNA samples compared with only com-
mercially extracted samples. Three 3-mm spots per sam-
ple per replicate were extracted using the commercial kit
or through the home protocol and then purified on the
column. The resulting purified DNA was eluted from the
column in 200 L of TE.
DNA Quantification
Samples were quantified using two established method-
ologies: 260/280 ratio via ND1000 Nanodrop (Thermo
Fisher Scientific, Waltham, MA) and DNA quantification
using fluorescence measurements. Because the 260/280
ratio overestimates the total amount of DNA15,16 and can-
not differentiate between protein and nucleic acid con-
tent in raw extracted samples, we used SYBR Green
(Invitrogen, Carlsbad, CA) DNA fluorescent measure-
ments17 of the samples and calculated the total DNA in
the sample by comparison to a standard curve using a
ND3300 Nanodrop (Thermo Fisher Scientific). In both
measurements, two 2-L replicate measurements per
DNA sample were obtained to ensure accuracy. Values
in this paper are presented from the more accurate SYBR
Green measurements unless otherwise stated.
DNA Quality and Utility PCR
A series of quality PCR amplicons were generated rang-
ing in size from 300 bp to 1000 bp.18,19 Primers previ-
ously designed for amplification and subsequent se-
quencing of known single nucleotide polymorphism
(SNP)-containing exons from disease-causing ion chan-
nel genes (RYR2, accession number NM_001035.2, and
HTR2A accession number NM_000839.3)5 were used un-
der optimized conditions. Using a high-fidelity proofread-
ing enzyme (Platinum Taq; Invitrogen), DNA was sub-
jected to an initial denaturation for 10 minutes at 94°C,
followed by 35 cycles of: i) denaturation at 94°C for 30
seconds; ii) annealing at 56°C for 1 minute; iii) elongation
at 72°C for 1 minute. A final 10-minute 72°C elongation
step allowed for completion of amplicons. The resulting
fragments were size-resolved on a 1.5% agarose gel and
subsequently excised, gel extracted (QIAquick Gel Ex-
traction Kit; Qiagen), and sequenced (Genewiz, South
Plainfield, NJ). Chromatograms were visually examined
and compared to a reference sequence for SNP detec-
tion. Control reactions were performed using high molec-
ular weight DNA extracted from venous blood (Puregene;
Qiagen) and DNA from the same individual reclaimed
from the Coriell cell-line repository.
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Comparative Analysis of ATS Processing
Informs Optimal, Sample-Specific DNA
Yield and Quality
We reviewed the literature for ATS protocols with regard
to the extraction procedure and sample utility. Methodol-
ogies varied according to the scientific field, species, or
tissue source and were optimized for an individually ap-
plicable analytical platform or singular endpoint such as
DNA animal genotyping, phylogenetic analysis, archival
sample analysis, forensic fingerprinting, or population
genetic screening. However, all protocols rely on three
basic processing steps: wash, extraction, and purifica-
tion (Figure 1A).
Sample Wash
Card-embedded blood spots were used to compare
the three established wash and/or rehydration solutions.
Figure 1. Comparison of experimental steps inform the development of an e
ATS samples were compared in this study, as well as the subsequent wash,
flow of the universal extraction protocol for Guthrie-based samples, wherea
obtained from 3-mm blood spots using three common wash solutions; TE (1
amounts; however, the addition of detergent produces a spot devoid of co
salt–containing extraction buffers (STE, PBS) with ProK had more total DNA
a raw DNA extract compatible with downstream applications without the
increasing number of blood spots in the extraction using the universal extract
card–based samples, including all ages of blood spots as well as buccal scrapes. In all
and distribution (dark half  25% to 50%; light half  50% to 75%; interface  meaQualitative assessment of 3-mm fresh blood spots after
washing with TE alone revealed that both the blood spot
and the supernatant were still obviously crimson colored
with unremoved heme proteins. Washing with SDS or
FTA resulted in a clear supernatant by the final wash
and a colorless spot. Quantitatively, the SDS-washed
spots yielded slightly more total DNA than the commer-
cial FTA reagent, 7.7  0.6 ng DNA (n  6) and 5.9 
0.8 ng DNA (n  6), respectively, and was similar in
yield to the TE wash alone (7.5  1.1 ng DNA; n  6).
Therefore, the Tris-SDS solution was selected as a
universally applicable wash solution for all subsequent
experiments (Figure 1B).
Sample Extraction
Card-embedded blood spots. DNA extraction from the
stabilizing paper matrix of the Guthrie card is best per-
formed by digestion with a proteolytic enzyme such as
ProK. We compared ProK digestion efficiency of fresh
blood spots in three common molecular biology buffers:
niversal extraction protocol for ATS samples. A: The flowchart defines which
n, and optional purification steps tested. The heavy black line shows the
tted line represents the workflow for nail-derived DNA. B: Total DNA yield
SDS (Tris/0.1% SDS), and FTA (FTA wash solution) in quantitatively similar
me and associate proteins. C: After 1 hour of incubation at 56°C, the high
m blood spots compared with TE/ProK; however, only DNA in TE produces
r additional DNA purification. D: Total DNA yield increased linearly with
ocol. E: The home protocol can reproducibly extract total DNA from Guthriefficient u
extractio
s the do
 TE),
lored he
yield fro
need fo
ion protpanels, the box plots represent both the range (error barsmin/max values)
n) of total DNA quantified using SYBR Green.
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56°C for 1 hour (Figure 1C; see also Supplemental Figure
S1 at http://jmd.amjpathol.org). Surprisingly, the lowest
average total DNA yield was obtained using TE (2.9 0.7
ng DNA; n 5) as compared to STE (14.1 2.6 ng DNA;
n  5), whereas extraction in PBS had a moderate DNA
yield (7.4  3.0 ng DNA; n  5) (Figure 1C). The range of
total DNA yield overlapped across all tested buffers, sug-
gesting that intersample variability was likely due to dif-
fering hematocrit concentrations rather than the extrac-
tion buffer.20 Even though TE did not facilitate the
maximal DNA extraction, it was selected as the preferred
extraction buffer because high salt concentrations in STE
and PBS can inhibit downstream molecular biology ap-
plications. To examine the effect of the sample input
amount on the final DNA yield, we performed five repli-
cate extraction series with increasing numbers of 3-mm
punches in a constant extraction volume (250 L). The
total DNA yield increased proportionally to the number of
punches without reaching a saturation point (Figure 1D).
The 3 3-mm punch extraction had the smallest variance
(10.2  0.7 ng DNA; n  5) and was selected as the
standardized sample size in the next step in which we
evaluated the effect of sample age on total DNA yield.
Replicate extractions revealed a general inverse correla-
tion between DNA yield and sample age (Figure 1E). The
fresh blood spots showed the highest yield but also the
largest variability in total DNA amount [fresh blood range:
0 ng to 47.3 ng (n  15); 1-week range: 6.0 to 19.6 ng
(n  10); aged range: 7.7 to 18.8 ng (n  15)]. This
suggests that consistent extraction requires time for the
sample to stabilize and be fully intercalated in the Guthrie
cotton cellulose matrix.21 We also assessed the efficacy
of our extraction protocol on Whatman FTA cards (What-
man, Maidstone, UK). Their matrix, although similar to
Guthrie cards, is impregnated with chemicals to more
efficiently lyse cells and stabilize DNA. Our protocol ex-
tracted only minimal and highly variable amounts of DNA
from FTA cards, ranging from 0 to 6.3 ng, regardless of
blood spot age (see Supplemental Figure S2 at http://
jmd.amjpathol.org). This is not surprising as other extrac-
tion protocols reported the need for an individually opti-
mized pH to achieve their optimal yields (110.2  77.3
ng) from three 3-mm punches.22
Buccal scrape on card. Using the protocol optimized for
blood spots, we extracted DNA from buccal scrapes on
Guthrie cards and found an average total DNA yield of
19.9  5.3 ng DNA (n  15) (Figure 1E). However, con-
siderable yield variability was again noted, ranging from
2.4 ng to 83.7 ng per 3-mm punch. This variability may be
attributed to unequal cell content within a singular buccal
scrape.23 The extraction efficiency from buccal scrapes
stabilized on FTA and Guthrie cards was similar to that
observed for blood spots, again favoring Guthrie cards
(see Supplemental Figure S2 at http://jmd.amjpathol.org).
Fingernail. Fingernails have long been used as a
source of DNA for forensic genotyping because of the
large amounts of DNA intercalated with the keratinized
matrix during nail growth.24 Although the nail structure
acts to stabilize the sample, we found that releasing the
DNA from the keratin matrix required modification of theextraction step that was otherwise optimal for blood spots
and buccal scrapes. The optimal temperature for keratin
digestion with ProK is 37°C, rather than the commonly
used 56°C, for an incubation period of variable dura-
tion.11,25 To define the optimal ratio between the diges-
tion time and total DNA yield, we digested 10 mg of
fingernail in TE with ProK for up to 48 hours (n  15). The
first raw extract fraction was removed at 18 hours (Day 1).
Following the addition of fresh extraction buffer and en-
zyme, the remaining fraction was incubated for 30 more
hours (Day 2). The average total DNA yields for Day 1
was 80.8  9.2 ng, and 40.2  8.7 ng for Day 2. The
prolonged 48-hour incubation increased total DNA yield
by 50% (see Supplemental Figure S3 at http://jmd.
amjpathol.org). In the interest of time, replicate digests
were subsequently performed for 24 hours at 37°C, with
an average DNA yield of 99.3  16.7 ng (n  15). This
was the largest amount of total DNA obtained from any
noninvasive sample assessed in this study.
Purification
Although the outlined protocols yield sufficient DNA
quantity, the downstream application of the raw DNA
extract may contain inhibitors, including proteins, salts,
and minerals, that could prevent PCR amplification of
gene targets.26 The QIAamp Mini Spin Kit produced con-
sistent, reliable DNA extraction fromGuthrie cards and buc-
cal scrapes. However, purification of raw DNA extract using
the commercial system considerably reduced the DNA re-
covery by an average of 38% (fresh blood spot extract),
44% (aged spot), and 43% (nail). The smallest average loss
of 9% was observed in buccal scrape samples (see Sup-
plemental Figure S4 at http://jmd.amjpathol.org).
Referential DNA extraction from conventional tissue
sources (venous blood, cell lines, saliva, and FFPE). Using
the Nanodrop1000 260/280 ratio, we measured total DNA
obtained from 96 samples purified from 9 mL of venous
blood. Although the average yield was 68.8  8.3 g of
DNA, the range varied greatly, from a low of 97.6 ng to a
high of 370 g. The average yield of DNA derived from
the corresponding 96 cell-line samples was 24.7  1.8
g DNA, with a range from 2 g to 91 g of DNA per
sample. Samples extracted from 2 mL of saliva using the
Oragene protocol had uniformly high yields, averaging
81.1 17 g (n 4). Finally, the replicate extractions of
four deparaffinized FFPE samples using the QIAamp
system yielded an average of 1.0  0.26 g of total
DNA, with a minimum yield of 298 ng and a maximum
yield of 1.4 g.
DNA Quality and Utility from ATS Is Comparable
to That from Conventional Samples
Quality PCR
The quality and utility of the ATS-derived DNA was
assessed by a PCR assay based on the ryanodine re-
ceptor gene, RYR2. Mutations in this gene are implicated
in sudden unexplained death and SUDEP, and reliable
detection is therefore important for medico-legal pur-
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sizes, in which we have previously identified SNPs.5
Amplicons up to 969 bp were generated from raw and
purified DNA samples derived from blood spots, residual
3-mm punches, and buccal samples (see Supplemental
Figure S5 at http://jmd.amjpathol.org). Moreover, the re-
sults obtained on Guthrie-embedded samples were iden-
tical to those from venous blood and immortalized cell
lines, indicating that the relatively low concentration of
DNA from Guthrie-based specimens is of sufficient qual-
ity to generate amplicons for downstream applications.
Unlike the Guthrie card samples, fingernail-based PCR
performance was the most variable, particularly with the
larger 969-bp amplicon (see Supplemental Figure S5 at
http://jmd.amjpathol.org). A second 911-bp amplicon
from the HTR2A serotonin receptor gene also failed to
amplify in the fingernail samples, suggesting potential
DNA degradation or fragmentation within the keratin
matrix.24
We next examined the amplification reliability in a se-
ries of DNA samples from an array of conventional and
alternative tissues. Since medical resequencing and mo-
lecular autopsy traditionally require amplicons of 500
bp,5 we selected the 456-bp amplicon of RYR2 exon 97
for testing. We noted 100% performance reliability in all
tissues except for the fingernail and FFPE-derived DNA
samples that showed amplification success rates of 66%
(n  9) and 25% (n  4), respectively (see Supplemental
Figure S5 at http://jmd.amjpathol.org). All samples dis-
played some variability in the amplification intensity that
was independent of template DNA concentration. The
fresh and aged blood spots were more variable than the
week-old samples, presumably from lack of matrix stabi-
lization of DNA in the former, and age-related degrada-
tion in the latter.
Comparative Utility in Sanger Sequencing
To determine the utility of noninvasive samples in
downstream genetic diagnostic applications, we submit-
ted the 456-bp amplicon from all tested tissue sources for
commercial Sanger sequencing (see Supplemental Fig-
ure S6 at http://jmd.amjpathol.org). Sequences from sali-
vary samples, blood spots, and buccal scrapes on Guth-
rie cards were comparable to those from venous blood
and cell line–derived DNA. Although the PCR-based am-
plicon generation was inconsistent for fingernail and
FFPE samples, those that did amplify produced high-
quality sequencing results comparable to the other
tested samples. These results suggest that the utility of a
sample may be primarily influenced by its ability to pro-
duce a robust and clean PCR amplicon, rather than by
source tissue type.
Discussion
Over the years, the process of tissue selection has been
driven by convention, convenience, or a history of sample
performance from high-profile scientific publications.29The overarching objective of this study was to providesystematic, comparative data on alternative tissues in
reference to conventional samples with regard to their
extraction properties9,20,21,23 and their performance in
downstream applications commonly used in individual-
ized risk prediction or postmortem analysis6,27,28 via
high-throughput medical diagnostics.2,3,11,30,31 It was in-
teresting to find that ATS were comparable to blood and
other tissue samples that, with the exception of FFPE, are
historically considered ideal specimens. The ease of col-
lection, storage, and lower cost of sample shipment and
extraction make ATS a valuable resource to stand alone
or complement other specimens that may be limited in
quality,32,33 scope,34,35 or yield36,37 (see Supplemental
Table S1 at http://jmd.amjpathol.org). Depending on the
research question, availability, or purpose, several differ-
ent tissues may need to be analyzed in parallel to obtain
an accurate genomic profile.38,39
Our literature review revealed considerable heteroge-
neity and conflicting extraction methodologies for alter-
native tissue sources, with few head-to-head compari-
sons of sample performance across analytical platforms.
Our approach was designed through analysis of the most
commonly cited protocols and was critically evaluated for
extraction efficiency and downstream molecular biology
utility in all ATS sample types after each of the key stages:
rehydration, extraction, and purification. The rehydrating
wash of Guthrie-based blood spots in our protocol was
greatly facilitated through the inclusion of a surfactant in
the Tris-SDS wash solution and produced a clean blood
spot sample open to direct PCR amplification or subse-
quent DNA extraction. Subsequent enzymatic digestion
with ProK in TE yielded consistent DNA extraction from
3 3-mm blood spots, where the low salt concentration in
TE made the raw DNA extract amenable to immediate
use for downstream molecular biology applications with
performance comparable to the purified product. Addi-
tionally, amplicons over 900 bp were reliably obtained
even from the residual trace sample in previously ex-
tracted blood spots, an important result in work with ar-
chival, nonrenewable blood cards; it indicates that our
protocol allows 100% utilization of every single blood
spot–derived punch. Moreover, serial replications and am-
plification of representative samples not only validated the
tested protocol, but also uncovered sample-specific incon-
sistencies. Nail and FFPE samples were themost variable in
DNA yield and amplification, with a failure rate of 20% for
nail and 80% for FFPE-derived DNA. This result has im-
portant implications for molecular autopsy. It indicates the
necessity for parallel extractions from multiple FFPE sam-
ples from the same individual, because a singular failed
sample may very likely prove to be falsely negative.
In summary, we performed direct comparisons of mul-
tiple alternative and conventional tissue sources and es-
tablished the utility and the value in sampling ATS, such
as blood spots, saliva, buccal scrapes, and nails, in lieu
of or in addition to peripheral blood, lymphoblastoid cell
lines, fresh frozen tissue, and FFPE samples. Although
broadly applicable for genomics research, our investiga-
tions also directly impact molecular autopsy studies,
where ATS may be the only source for defining the cause
of death, allowing collection of essential medico-legal
Utility of DNA from Alternate Tissues 457
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consequential for the surviving family.
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